Veru Inc.
VERU
$0.6398
$0.149730.55%
| Weiss Ratings | VERU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | VERU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | VERU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.26 | |||
| Price History | VERU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 26.74% | |||
| 30-Day Total Return | 18.20% | |||
| 60-Day Total Return | -1.64% | |||
| 90-Day Total Return | 9.63% | |||
| Year to Date Total Return | -1.84% | |||
| 1-Year Total Return | -15.82% | |||
| 2-Year Total Return | -51.53% | |||
| 3-Year Total Return | -87.65% | |||
| 5-Year Total Return | -80.43% | |||
| 52-Week High % Change | -73.54% | |||
| 52-Week Low % Change | 12.91% | |||
| Price | VERU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.92 | |||
| 52-Week Low Price | $0.45 | |||
| 52-Week Low Price (Date) | Mar 14, 2025 | |||
| 52-Week High Price (Date) | Apr 11, 2024 | |||
| Valuation | VERU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 74.38M | |||
| Enterprise Value | 51.69M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.26 | |||
| Earnings Per Share Growth | -64.02% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 5.05 | |||
| Price/Book (Q) | 2.79 | |||
| Enterprise Value/Revenue (TTM) | 3.51 | |||
| Price | $0.64 | |||
| Enterprise Value/EBITDA (TTM) | -1.29 | |||
| Enterprise Value/EBIT | -1.28 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | VERU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 146.38M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $0.07 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $0.07 | |||
| Company Info | VERU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 305 509 6897 | |||
| Address | 2916 North Miami Avenue Miami, FL 33127 | |||
| Website | verupharma.com | |||
| Country | United States | |||
| Year Founded | 1971 | |||
| Profitability | VERU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -273.17% | |||
| Profit Margin | -260.89% | |||
| Management Effectiveness | VERU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -41.82% | |||
| Return on Equity | -- | |||
| Income Statement | VERU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 14.75M | |||
| Total Revenue (TTM) | 14.75M | |||
| Revenue Per Share | $0.10 | |||
| Gross Profit (TTM) | 4.70M | |||
| EBITDA (TTM) | -40.02M | |||
| EBIT (TTM) | -40.28M | |||
| Net Income (TTM) | -38.47M | |||
| Net Income Avl. to Common (TTM) | -38.47M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 76.39% | |||
| EPS Diluted (TTM) | -0.26 | |||
| EPS Diluted Growth (Q YOY) | 25.76% | |||
| Balance Sheet | VERU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 26.21M | |||
| Cash Per Share (Q) | $0.18 | |||
| Total Current Assets (Q) | 28.38M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 26.63M | |||
| Current Ratio (Q) | 4.471 | |||
| Book Value Per Share (Q) | $0.18 | |||
| Total Assets (Q) | 39.83M | |||
| Total Current Liabilities (Q) | 6.35M | |||
| Total Debt (Q) | 3.52M | |||
| Total Liabilities (Q) | 13.20M | |||
| Total Common Equity (Q) | 26.63M | |||
| Cash Flow | VERU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 17.39M | |||
| Cash from Financing (TTM) | -4.37M | |||
| Net Change in Cash (TTM) | -13.97M | |||
| Levered Free Cash Flow (TTM) | -10.89M | |||
| Cash from Operations (TTM) | -26.99M | |||
